» Authors » Carlos Alvarez-Moreno

Carlos Alvarez-Moreno

Explore the profile of Carlos Alvarez-Moreno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 1000
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Burgos C, Mendez L, Rodriguez M, Martinez A, Sanchez P, Tovar C, et al.
Pediatr Pulmonol . 2025 Feb; 60(3):e27495. PMID: 40018994
Background: Despite advancements in vaccination and the transition from pandemic to endemic, SARS-CoV-2 continues to pose a medical challenge, particularly among children. In this context, imaging diagnostics, such as chest...
2.
Valderrama-Beltran S, Cuervo-Rojas J, Rondon M, Montealegre-Diaz J, Vera J, Martinez-Vernaza S, et al.
PLoS One . 2024 Dec; 19(12):e0316207. PMID: 39724211
Background: Despite declining COVID-19 incidence, healthcare workers (HCWs) still face an elevated risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. We developed a diagnostic multivariate model to predict...
3.
Espinosa O, White L, Bejarano V, Aguas R, Rincon D, Mora L, et al.
Heliyon . 2024 Nov; 10(21):e39725. PMID: 39559218
The uncertainty associated with the future of viruses such as SARS-CoV-2 poses a challenge to public health officials because of its implications for welfare, economics and population health. In this...
4.
Espinosa O, Mora L, Sanabria C, Ramos A, Rincon D, Bejarano V, et al.
Syst Rev . 2024 Jan; 13(1):30. PMID: 38229123
Background: The interaction between modelers and policymakers is becoming more common due to the increase in computing speed seen in recent decades. The recent pandemic caused by the SARS-CoV-2 virus...
5.
Alvarez-Moreno C, Valderrama-Beltran S, Silva R, De La Hoz Siegler I, Varon Vega F, Martinez-Vernaza S, et al.
Travel Med Infect Dis . 2023 May; 53:102579. PMID: 37169233
Objectives: To evaluate the association between Colombia's third wave when the Mu variant was predominant epidemiologically (until 75%) in Colombia and COVID-19 all-cause in-hospital mortality. Methods: In this retrospective cohort,...
6.
Montero C, Torres R, Benavidez C, Garcia P, Jimenez S, Yomayusa N, et al.
Nefrologia (Engl Ed) . 2023 Jan; 43(6):757-764. PMID: 36681519
Background: The impact of immunosuppression in solid organ transplant recipients with SARS-CoV-2 infection is unknown. The knowledge about the behavior of different immunosuppression schemes in clinical outcomes is scarce. This...
7.
Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu N, Chuenkitmongkol S, et al.
Expert Rev Vaccines . 2022 Nov; 22(1):1-16. PMID: 36330971
Introduction: COVID-19 vaccines have been highly effective in reducing morbidity and mortality during the pandemic. However, the emergence of the Omicron variant and subvariants as the globally dominant strains have...
8.
Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu N, Chuenkitmongkol S, et al.
Expert Rev Vaccines . 2022 Aug; 21(9):1355-1357. PMID: 35968671
No abstract available.
9.
Valderrama-Beltran S, Martinez-Vernaza S, Figueredo M, Martinez E, Blair K, Cuervo-Rojas J, et al.
Int J STD AIDS . 2022 May; 33(7):641-651. PMID: 35502981
Introduction: HIV is an independent risk factor for cardiovascular diseases (CVD). There is insufficient information regarding comorbidities and cardiovascular risk factors in the Colombian HIV population. The aim of this...
10.
Ceballos-Garzon A, Garcia-Effron G, Cordoba S, Rodriguez J, Alvarez-Moreno C, Le Pape P, et al.
Int J Antimicrob Agents . 2022 Mar; 59(4):106558. PMID: 35227828
The susceptibility of 31 Candida auris clinical isolates was evaluated by four methods, namely the microdilution reference method according to Clinical and Laboratory Standards Institute (CLSI) and European Committee on...